Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Faculty of Science and Technology, Division of Molecular Science, Gunma University, Kiryu, Gunma, Japan.
Oncol Res. 2019 Jun 21;27(6):713-727. doi: 10.3727/096504018X15433161908259. Epub 2019 Mar 8.
The fertile stroma in pancreatic ductal adenocarcinomas (PDACs) has been suspected to greatly contribute to PDAC progression. Since the main cell constituents of the stroma are fibroblasts, there is crosstalking(s) between PDAC cells and surrounding fibroblasts in the stroma, which induces a fibroblast proliferation burst. We have reported that several malignant cancer cells including PDAC cells secrete a pronounced level of S100A11, which in turn stimulates proliferation of cancer cells via the receptor for advanced glycation end products (RAGE) in an autocrine manner. Owing to the RAGE expression in fibroblasts, the extracellular abundant S100A11 will affect adjacent fibroblasts. In this study, we investigated the significance of the paracrine axis of S100A11-RAGE in fibroblasts for their proliferation activity. In in vitro settings, extracellular S100A11 induced upregulation of fibroblast proliferation. Our mechanistic studies revealed that the induction is through RAGE-MyD88-mTOR-p70 S6 kinase upon S100A11 stimulation. The paracrine effect on fibroblasts is linked mainly to triggering growth but not cellular motility. Thus, the identified pathway might become a potential therapeutic target to suppress PDAC progression through preventing PDAC-associated fibroblast proliferation.
胰腺导管腺癌 (PDAC) 中的肥沃基质被怀疑极大地促进了 PDAC 的进展。由于基质的主要细胞成分是成纤维细胞,因此 PDAC 细胞与基质中的周围成纤维细胞之间存在串扰,这会诱导成纤维细胞增殖爆发。我们已经报道了包括 PDAC 细胞在内的几种恶性癌细胞会大量分泌 S100A11,它通过晚期糖基化终产物受体 (RAGE) 以自分泌的方式刺激癌细胞的增殖。由于成纤维细胞中表达 RAGE,细胞外大量的 S100A11 将影响邻近的成纤维细胞。在这项研究中,我们研究了 S100A11-RAGE 旁分泌轴对成纤维细胞增殖活性的意义。在体外环境中,细胞外 S100A11 诱导成纤维细胞增殖的上调。我们的机制研究表明,这种诱导是通过 S100A11 刺激后 RAGE-MyD88-mTOR-p70 S6 激酶实现的。旁分泌对成纤维细胞的作用主要与触发生长而不是细胞迁移有关。因此,所鉴定的途径可能成为通过防止 PDAC 相关成纤维细胞增殖来抑制 PDAC 进展的潜在治疗靶点。